ALCOX:EPA
NicOx SA
€0.31
arrow_downward
-1.26%(-0.0040) 1D
Oct 7, 3:06:36 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€0.32
High
€0.32
Low
€0.31
Mkt. cap
29.81M
Avg. vol.
167.87K
Volume
203.53K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
97.55M
No. of employees
10
Open
€0.32
High
€0.32
Low
€0.31
Mkt. cap
29.81M
Avg. vol.
167.87K
Volume
203.53K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
97.55M
No. of employees
10
News stories
From web sources and news partners
Invezz
·
7 minutes ago
Dow opens 400 pts lower as oil and Treasury yields rise ahead of Fed minutes
RealClearMarkets
·
26 minutes ago
Magnificent 7 Take the S&P 500 Back To Record Highs
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, France
SectorBiotechnology
Websitenicox.com